Beijing Konruns Pharmaceutical Co., Ltd. (603590.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 28.59

From 52W high−49.56%

Volume1.48M

Market capCNY 4.79B

P/E (TTM)28.9x

P/S (TTM)5.0x

Div yield1.22%

Key dataSep 18, 2026

Open

CNY 28.59

From 52W high

−49.56%

Volume

1.48M

Market cap

CNY 4.79B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

20.4x

P/E (TTM)

28.9x

RSI (14)

40.1

MomentumView details →

1D Return

−6.49%

YTD Return

−27.55%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

28.9x

EV/EBITDA

20.4x

EV/Sales

5.3x

P/S (TTM)

5.0x

P/B (TTM)

1.5x

ProfitabilityView details →

Gross Margin

89.84%

Net Margin

18.38%

EBITDA Margin

25.77%

ROE (TTM)

5.24%

ROA (TTM)

4.14%

Asset Turnover

0.22x

GrowthView details →

Revenue YoY

+9.52%

EPS YoY

+282.79%

FCF YoY

+913.68%

Revenue CAGR 3Y

+1.83%

EPS CAGR 3Y

+17.33%

EBITDA YoY

—

MomentumView details →

1D Return

−6.49%

YTD Return

−27.55%

1Y Return

−48.89%

RSI (14)

40.1

vs 50D SMA

−8.58%

vs 200D SMA

−20.73%

Capital & dividendView details →

Debt/Equity

0.10x

Current Ratio

3.05x

Quick Ratio

2.91x

Div Yield

1.22%

Div Rate

CNY 0.35

Div Growth 1Y

−41.67%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

917.99M

Net Income (TTM)

168.68M

Op. CF (TTM)

167.79M

Latest newsMore news →

Kangchen Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 95.7226 million yuan, up 5.14% year-on-year.26d ago

Similar companies

科兴制药688136.SH ACADIA Pharmaceuticals Inc.ACAD 三力制药603439.SH Edgewise Therapeutics, Inc.EWTX Iovance Biotherapeutics, Inc.IOVA Adaptive Biotechnologies CorporationADPT Find similar companies →

Latest newsMore news →

Kangchen Pharmaceutical announced its first-half 2026 results: net profit attributable to shareholders was 95.7226 million yuan, up 5.14% year-on-year.26d ago